Omnicell (OMCL) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53% |
| Mar 31, 2026 | -4.27% |
| Dec 31, 2025 | -16.26% |
| Sep 30, 2025 | -9.11% |
| Jun 30, 2025 | 27.06% |
| Mar 31, 2025 | -21.25% |
| Dec 31, 2024 | -6.44% |
| Sep 30, 2024 | -15.46% |
| Jun 30, 2024 | -25.22% |
| Mar 31, 2024 | -46.55% |
| Dec 31, 2023 | -24.34% |
| Sep 30, 2023 | -16.44% |
| Jun 30, 2023 | -12.13% |
| Mar 31, 2023 | -49.66% |
| Dec 31, 2022 | -23.82% |
| Sep 30, 2022 | 16.70% |
| Jun 30, 2022 | 36.99% |
| Mar 31, 2022 | 22.82% |
| Dec 31, 2021 | 8.47% |
| Sep 30, 2021 | 71.38% |